Tilray Inc. (TLRY) stock surged 6.98% in pre-market trading on Monday, building on the momentum from a 5.23% gain in the previous trading session. The cannabis company's shares are rallying in response to a highly bullish analyst report from TD Cowen, which has significantly boosted investor confidence.

TD Cowen analyst Robert Moskow reaffirmed his Buy rating on Tilray and dramatically increased the price target from $0.80 to $2.50, representing a substantial hike of over 200%. This upgrade reflects growing optimism about Tilray's growth potential and strategic market positioning within the cannabis industry. Moskow's decision to maintain a Buy rating while more than tripling the price target suggests a notably improved outlook for the company's future prospects.

The market's strong reaction to this analyst upgrade underscores the impact of expert opinions on investor sentiment, particularly in the volatile cannabis sector. While the specific details of Moskow's analysis were not provided, the magnitude of the price target increase has clearly resonated with investors, driving the stock's impressive pre-market performance. However, as with any analyst recommendation, investors are advised to consider a wide range of factors, including the company's financials, industry trends, and overall market conditions, before making investment decisions.